Research Topic · Peer-Reviewed

Adenocarcinoma Cells

Adenocarcinoma cells are cancerous cells that originate from glandular structures. These structures can be found in various organs such as the lung, pancreas, breast, and prostate. Adenocarcinomas are particularly common in the colon where they account for the majority of colorectal cancers. Hematology and oncolog…

Curated from this journal's research 📚 10 peer-reviewed articles cited Cited 35× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed June 2026

Overview

Adenocarcinoma cells are cancerous cells that originate from glandular structures. These structures can be found in various organs such as the lung, pancreas, breast, and prostate. Adenocarcinomas are particularly common in the colon where they account for the majority of colorectal cancers. Hematology and oncology research have shown that adenocarcinoma cells are particularly aggressive and can spread rapidly to other organs when left untreated. Therefore, early detection and diagnosis is key to improving the chances of successful treatment. One of the primary methods of diagnosing adenocarcinoma is through a biopsy, where a tissue sample is taken and analyzed for the presence of abnormal cells. Hematology and oncology researchers have also identified various genetic mutations and alterations that are associated with adenocarcinoma development. Understanding these genetic markers can help to develop targeted therapies that are tailored to a patient's specific genetic makeup. Treatment options for adenocarcinoma vary depending on the location and stage of the cancer. Hematology and oncology research have found that surgery, chemotherapy, and radiation therapy are the most commonly used treatments. However, a combination of these therapies may be necessary to effectively manage and treat the cancer. In conclusion, understanding adenocarcinoma cells and the various treatments available is crucial in achieving positive outcomes for patients. Further research is needed to better understand the genetic components of this cancer and to develop targeted therapies that offer tailored treatments for patients.

Research published in this journal

10 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 10 articles above have been cited 35 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Adenocarcinoma Cells, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.